- Home
- IGD vs KMDA Comparison
IGD vs KMDA Comparison
Compare IGD & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGD
- KMDA
- Stock Information
- Founded
- IGD N/A
- KMDA 1990
- Country
- IGD United States
- KMDA Israel
- Employees
- IGD N/A
- KMDA N/A
- Industry
- IGD Trusts Except Educational Religious and Charitable
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- IGD Finance
- KMDA Health Care
- Exchange
- IGD Nasdaq
- KMDA Nasdaq
- Market Cap
- IGD 422.7M
- KMDA 399.7M
- IPO Year
- IGD N/A
- KMDA N/A
- Fundamental
- Price
- IGD $5.65
- KMDA $6.78
- Analyst Decision
- IGD
- KMDA Strong Buy
- Analyst Count
- IGD 0
- KMDA 3
- Target Price
- IGD N/A
- KMDA $14.67
- AVG Volume (30 Days)
- IGD 215.3K
- KMDA 79.3K
- Earning Date
- IGD 01-01-0001
- KMDA 05-14-2025
- Dividend Yield
- IGD 9.15%
- KMDA 2.96%
- EPS Growth
- IGD N/A
- KMDA 31.21
- EPS
- IGD N/A
- KMDA 0.28
- Revenue
- IGD N/A
- KMDA $167,235,000.00
- Revenue This Year
- IGD N/A
- KMDA $14.51
- Revenue Next Year
- IGD N/A
- KMDA $9.31
- P/E Ratio
- IGD N/A
- KMDA $23.98
- Revenue Growth
- IGD N/A
- KMDA 11.83
- 52 Week Low
- IGD $4.60
- KMDA $4.74
- 52 Week High
- IGD $5.26
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- IGD 51.03
- KMDA 50.37
- Support Level
- IGD $5.63
- KMDA $6.64
- Resistance Level
- IGD $5.72
- KMDA $6.99
- Average True Range (ATR)
- IGD 0.05
- KMDA 0.17
- MACD
- IGD -0.01
- KMDA -0.02
- Stochastic Oscillator
- IGD 33.33
- KMDA 44.00
About IGD Voya Global Equity Dividend and Premium Opportunity Fund
Voya Global Equity Dividend and Premium Opportunity Fund are a United States-based diversified, closed-end Fund. The primary objective of the Fund is to seek to provide investors with a high level of income from a portfolio of common stocks with historically attractive dividend yields and premiums from call option writing. The secondary investment objective of the company is capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in a portfolio of common stocks of dividend-paying companies located throughout the world.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.